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The intracellular localization of hepatitis C virus structural proteins was analyzed by confocal immunofluorescence
microscopy, cell fractionation, and immunoelectron microscopy in stably transfected cells that do not overexpress the viral
proteins. The results strongly suggest that at steady state the structural proteins reside not only in the endoplasmic reticulum
but also in the intermediate compartment and cis-Golgi complex region. By analogy with other viral systems, this finding
raises the possibility that the intermediate compartment and cis-Golgi complex play a role in the assembly and budding of
hepatitis C virus. © 2001 Academic PressINTRODUCTION
Hepatitis C virus does not replicate in tissue-cultured
cells, thus very little is known about the assembly and
budding of the viral progeny. Several reports of transfec-
tion experiments have documented that the three struc-
tural proteins (core and glycoproteins E1 and E2) do not
reach the plasma membrane but accumulate in internal
membranes, identified as ER,2 and that the glycoproteins
orm variable amounts of unfolded/misfolded aggregates
Choukhi et al., 1998; Dubuisson et al., 1994; Ralston et
al., 1993; Santolini et al., 1994; Selby et al., 1993). Both
features probably contribute to the low level of assembly
of the progeny virus in the infected individuals. In addi-
tion, the absence of surface exposure of the glycopro-
teins may play a role in impairment of an efficient re-
sponse of the host immune system, thus favoring the
development of persistent infection. However, most of
the studies mentioned above were performed after tran-
sient transfections in which the glycoproteins were over-
expressed with strong promoters. This situation en-
hances the amount of unfolded/misfolded aggregates
destined to be retained in the ER because of the inability
of the protein to pass the quality control process (Ell-
gaard et al., 1999). Therefore, to determine the intracel-
lular localization of HCV structural proteins, we have
chosen as model system the stably transfected clone
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176HCV1b-4 (Santolini et al., 1994), isolated from CV1 cells.
In this clone, the expression of the viral structural pro-
teins coded by the HCV-BK strain is under the control of
an inducible promoter, which allows the modulation of
the amount of protein synthesized. In this paper, we
present results from morphological and cell fractionation
studies showing that HCV structural proteins are not
confined to the ER but are also present in the IC and
cis-Golgi complex of HCV1b-4 cells.
RESULTS AND DISCUSSION
First we analyzed by immunofluorescence microscopy
the biosynthesis of HCV structural proteins in HCV1b-4
cells. These cells have integrated the pHMT(HCV1b)
plasmid that contains the metal-inducible human metal-
lothionein IIa promoter to drive the transcription of a
truncated mRNA expressing the first 861 aa residues of
HCV polyprotein (Santolini et al., 1994; Schmidt et al.,
1985). HCV proteins were not detectable in the absence
of induction: they started to appear about 6 h postinduc-
tion with 5 mM CdCl2, to reach maximum expression at
12–14 h (data not shown). Thus, we chose 9 h of induc-
tion, a time point that showed suboptimal synthesis in
the absence of morphological alteration of the cells. At
this time of induction, E2 and core proteins appeared in
Western blot analysis after SDS–PAGE as single bands of
the expected molecular weight of about 70 and 20 kDa,
respectively (Fig. 1A). E1 protein was not detected by E1a
antibody, which worked poorly in Western blot and im-
munoprecipitation analyses. However, the protein order
on the HCV polyprotein precursor (core–E1–E2 from the
aminoterminus), the results described in Fig. 1, and the
immunofluorescence evidence (see below) make it likely
that E1 glycoprotein was synthesized by these cells.
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proteins tend to form covalently and noncovalently
bound oligomeric aggregates in highly expressing cells
(Choukhi et al., 1998; Dubuisson et al., 1994; Ralston et
al., 1993; Selby et al., 1993), so we addressed this point
in induced HCV1b-4 cells. When the reduction step in the
SDS–PAGE analysis was omitted (Fig. 1A), core protein
migration was unchanged and E2 glycoprotein migrated
as a single band of about 140 kDa, in the absence of
higher molecular weight aggregates. This band most
likely represents E2 homodimers stabilized by disulfide
bridges. When the HCV proteins were analyzed by su-
crose velocity gradients (Figs. 1B and 1C), core and E2
protein sedimented mostly as monomer and dimer, re-
spectively. Only about 10% of E2 glycoprotein sedi-
mented at the bottom of the gradient (fractions 1–5), as
noncovalently or covalently bound high-molecular-
weight aggregate. Thus, under the conditions used,
HCV1b-4 cells synthesized HCV structural proteins with
FIG. 1. Biosynthesis of HCV structural proteins in HCV1b-4 cells. The
and Methods. (A) Parallel aliquots of the lysate were processed for SD
Western blot analysis developed with anti-core or anti-E2 glycoprotein
the left. E2 and core protein were analyzed on 10 and 12.5% gels, res
Material and Methods) and the content of the collected fractions analy
the position of the 52-kDa marker and the two halves were incubated w
positions of molecular weight markers (in kDa) run in a parallel gradient
in B was quantified by laser scanning and reported as percentage ofnegligible level of aggregation, at variance with other
expression systems (Dubuisson et al., 1994; Ralston etal., 1993; Selby et al., 1993). This finding allowed us to
move to immunolocalization experiments based on con-
focal immunofluorescence microscopy, confident that
the results should not be disturbed by protein overex-
pression. In agreement with previous reports (Choukhi et
al., 1998; Dubuisson et al., 1994; Ralston et al., 1993;
Santolini et al., 1994; Selby et al., 1993), all proteins were
found in intracellular membranes, largely corresponding
to the ER, as indicated by the overlap with the ER protein
marker calnexin (Fig. 2; Ellgaard et al., 1999). No differ-
ence was detected in the distribution of E1, E2, and core
proteins (Fig. 2). Interestingly, the glycoproteins did not
change their distribution when expressed in the absence
of core protein (in the clone HCV2b-4, data not shown; Lo
et al., 1996; Santolini et al., 1994). Finally, at variance with
other cell lines (Hsieh et al., 1998; Liu et al., 1997; Yasui
et al., 1998), the core protein was not seen in the nucleus
of HCV1b-4 cells.
Next we studied the distribution of glycoprotein E2 by
were induced with CdCl2 for 9 h and lysed as detailed under Material
E, in the presence or absence of reducing agents (DTT), followed by
y. The positions of molecular weight markers (in kDa) are indicated on
ly. (B) The lysate was centrifuged on a velocity sucrose gradient (see
12.5% SDS–PAGE and Western blot. The nitrocellulose filter was cut at
R21 and C1 antibodies to detect E2 and core protein, respectively. The
icated at the top. (C) The amount of each protein in the fractions shown
he profile of the sucrose gradient is indicated.cells
S–PAG
antibod
pective
zed by
ith thecell fractionation (Erra et al., 1999). As shown in Fig. 3,
the majority of E2 glycoprotein cosedimented with the
age of
E2 pr
178 MARTIRE ET AL.ER, but a significant portion trailed in the Golgi and IC
region, indicated by ERGIC-P53 and GS28, prototype
protein markers for the IC and cis-Golgi complex, re-
spectively (Schweizer et al., 1988; Subramanian et al.,
1996). Therefore, to establish if a fraction of HCV struc-
tural proteins is indeed present in the IC and cis-Golgi
complex, we performed additional confocal light micros-
copy assays. As shown in Fig. 4, a fraction of E2 and core
proteins did colocalize in the perinuclear region with
ERGIC-P53 and GS28 proteins. Conversely, calnexin and
ERGIC-P53 did not colocalize (Fig. 4c), indicating that ER
and IC were not altered in these cells. As expected,
ERGIC-P53 and GS28 showed only a minor overlap (not
shown), and all the results were confirmed by analysis of
single optical sections (Fig. 4, SS). In addition, E2 and
GS28 protein did show a partial colocalization in cells
induced for only 7.5 h (data not shown). Given that only a
very small amount of viral proteins is accumulated in
cells induced for 7.5 h compared to 9 h, the localization
of HCV structural proteins in the IC/cis-Golgi region does
not appear to depend on their expression levels.
In order to obtain definitive evidence on the presence
FIG. 2. Colocalization in the ER of HCV structural proteins. HCV1b-4
indirect immunofluorescence analysis, and viewed with a laser confoc
optical sections, of the single signals (first two images from the le
colocalization); in the fourth panel (SS) is presented the bidimensional im
signals). The C1 and R21 antibodies were used for detecting core andof HCV structural proteins in the IC/cis-Golgi region, we
analyzed the intracellular localization of E2 glycoproteinby immunoelectron microscopy of ultrathin cryosections.
As shown in Fig. 5, the immunogold labeling of E2 gly-
coprotein appeared mostly present on ER membranes
(Figs. 5a and 5b), but specific immunolabeling was also
observed on several vesicles and small tubules of the IC
as well as over cis-Golgi cisternae and associated ves-
icles (Figs. 5c and 5d). Plasma membranes and endoso-
mal compartments appeared unlabeled (not shown), and
no viruslike particles were detected in the cells (Baumert
et al., 1998). Thus, although it was not possible to extend
these results to core and E1 protein because the specific
antibodies worked poorly in immunoelectron micros-
copy, all the results strongly indicated that a fraction of
HCV structural proteins is present in the IC/cis-Golgi
region of HCV1b-4 cells. Finally, in a first attempt to
compare the structural proteins present in the IC/cis-
Golgi region with those contained in the ER, we analyzed
by velocity sucrose gradient the oligomerization condi-
tion of the E2 glycoprotein forms present in the ER- and
IC/cis-Golgi-enriched regions of the cell fractionation
gradient. The two profiles were very similar to each other
and to the one reported in Fig. 1C (data not shown).
ere cultured on glass coverslips, metal-induced, processed for double
oscope (LCM Zeiss 310). (a–c) Tridimensional reconstruction, from all
of the superimposed signals (MERGE; the yellow color indicates
a single 0.5-mm optical section (showing in white only the colocalizing
oteins, respectively. CLNX, calnexin.cells w
al micr
ft) andHowever, the aggregated material sedimenting in the
bottom of the gradient was enriched in the ER pool,
roteins
oteins
179INTRACELLULAR LOCALIZATION OF HCV STRUCTURAL PROTEINSsuggesting that the E2 forms that leave the ER have
FIG. 3. HCV E2 glycoprotein is not confined to the ER. Analysis of th
fraction from induced HCV1b-4 cells. Postnuclear supernatants from in
in 20 mM HEPES–KOH, pH 7.4/0.5 mM EDTA) that was spun for 1 h a
analyzed by 10% SDS–PAGE and Western blot to reveal the indicated p
scanning. (A) % distribution of each protein. (B) Immunoblots of the prsuccessfully undergone the quality control process (data
not shown).It is well documented that HCV glycoproteins do not
entation on a sucrose density gradient of a postnuclear supernatant
cells were loaded on top of a discontinuous sucrose gradient (20–60%
m in a Beckman SW50.1. Same-size aliquots from each fraction were
. The amount of each protein in the fractions was quantified by laser
tested. The anti-E2 R21 antibody was used.e sedim
duced
t 43K rpacquire Endo H resistance (Deleersnyder et al., 1997;
Dubuisson et al., 1994; Fournillier-Jacob et al., 1996; Ral-
t
d
p
r Fig. 2.
180 MARTIRE ET AL.ston et al., 1993), suggesting that they do not reach the
medial/trans-Golgi regions of the secretory pathway. Re-
cently, this finding has been extended by analysis of the
N-glycans of HCV glycoproteins (Duvet et al., 1998; Mot-
tola et al., 2000). No modifications due to Golgi-resident
enzymes were detected, and this led to the proposal that
FIG. 4. Localization of a fraction of E2 and core proteins in the IC an
analysis and viewed with a laser confocal microscope as described fo
were used for detecting core and E2 proteins, respectively.HCV glycoproteins are tightly retained in the ER (Duvet et
al., 1998), thanks also to the presence of specific reten-ion signals (Duvet et al., 1998; Mottola et al., 2000), and
o not recycle from the Golgi complex as other ER
roteins (Martire et al., 1996; Lotti et al., 1999). However,
there is no compelling evidence in the literature that
N-glycans-modifying enzymes reside in the IC/cis-Golgi
complex; thus, the results we present herein do not
olgi complex. HCV1b-4 cells were processed for immunofluorescence
The results are presented as in Fig. 2. The F8B12 and R21 antibodiesd cis-Gconflict with the previously mentioned results. On the
other hand, it is well known that different viruses start
181INTRACELLULAR LOCALIZATION OF HCV STRUCTURAL PROTEINStheir assembly in the IC/cis-Golgi region (Griffiths and
Rottier, 1992; Klumpermann et al., 1994; Peterson, 1991).
Therefore, an interesting alternative hypothesis is that
the HCV structural proteins that go beyond the ER in the
secretory pathway are the ones that start the low level of
virus assembly and budding which is responsible for
HCV spreading in the natural host. The fact that at steady
state only a fraction of the proteins is in the IC/cis-Golgi
region, while the majority stays in the ER, must be con-
sidered with caution: it is concentration rather than ab-
solute quantity to drive viral assembly and budding, and
it is known that the ER has a much larger surface area
than the IC and cis-Golgi complex (Griffiths, 1993; Lotti et
al., 1999). Obviously, further work is needed to test the
role of the IC and cis-Golgi complex in HCV assembly. It
will be important to compare the concentration of HCV
structural proteins in the ER and IC/cis-Golgi region, to
verify if the HCV-H strain reproduces the results obtained
FIG. 5. Immunogold electron microscopical analysis of the localiza-
tion of HCV E2 glycoprotein in HCV1b-4 cells. After induction, the cells
were processed for cryosectioning and immunogold analysis. The
immunolabeling of E2 glycoprotein is mostly associated with ER mem-
branes (a, b, arrows); gold particles are also observed on vesicles and
small tubules on the IC (c, arrows), as well as on Golgi cisternae
(cis-Golgi by morphological criteria) and peripheral Golgi-associated
vesicles (d, arrows). The anti-E2 R21 antibody was used. er, endoplas-
mic reticulum; G, Golgi complex; bars, 0.2 mm.with the BK strain, and to determine if the structural
proteins that are present in the IC/cis-Golgi region aredifferent from their counterparts present in the ER. Fi-
nally, an interesting model system has been recently
described for studying the replication of a subgenomic
HCV RNA that codes for all the nonstructural proteins in
stably transfected cells (Lohmann et al., 1999). Hopefully,
this approach will be developed to provide a model
system for the replication of the entire HCV genome. In
the meantime, although the structural protein portion is
not present in the subgenomic RNA, it would be inter-
esting to see if ER and IC/cis-Golgi region membranes
play a role in this replication process.
MATERIAL AND METHODS
Materials
All culture reagents were supplied by Sigma–Aldrich
(Milan, Italy). Solid chemicals and liquid reagents were
obtained from E. Merck (Darmstadt, Germany), Farmitalia
Carlo Erba (Milan, Italy), Serva Feinbiochemica (Heidel-
berg, Germany), and BDH (Poole, United Kingdom). The
ECL kit was from Amersham–Pharmacia Biotech (Milan,
Italy). The following antibodies were used: mouse mAb
E1A (anti-E1 glycoprotein; Dubuisson et al., 1994), rabbit
polyclonal R21 and mouse mAb 185A (anti-E2 glycopro-
tein; Santolini et al., 1994), mouse mAb C1 (anti-core
protein), F8B12 human mAb F8B12 (anti-core protein;
Santolini et al., 1994), mouse mAb anti-GS28 protein
(Subramanian et al., 1996), mouse mAb G1/93 (anti-ER-
GIC-53 protein; Schweitzer et al., 1988), rabbit polyclonal
anti-calnexin (Lotti et al., 1999), peroxidase-conjugated
anti-mouse and anti-rabbit IgG (Sigma-Aldrich), and
Texas red-conjugated anti-mouse IgG and fluorescein-
conjugated anti-rabbit IgG (Jackson Immunoresearch
Laboratories, West Grove, PA).
Cell culture, preparation of cells extracts, SDS–PAGE
and Western blotting, and velocity sucrose gradient
analysis
HCV1b-4 cells were cultured as described previously
(Santolini et al., 1994) and lysed with 10 mM Tris–HCl, pH
7.4, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 20 mM
NEM; aliquots of the lysate were processed for SDS–
PAGE and Western blotting as detailed elsewhere (Mar-
tire et al., 1996; Mottola et al., 2000). Alternatively, the cell
lysates (1 ml) were analyzed on an 11-ml linear 5–20%
sucrose gradient made up in lysis buffer (without NEM)
and run in a Beckman SW 41 rotor for 19 h at 4°C.
Fractions were collected from the bottom, concentrated
by TCA precipitation, and analyzed by SDS–PAGE fol-
lowed by Western blot.
Cell fractionationCell fractionation was performed exactly as detailed
previously (Erra et al., 1999). The single fractions were
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PAGE followed by Western blot.
Indirect immunofluorescence and immunoelectron
microscopy
Cells grown on glass coverslips were fixed with 4%
formaldehyde for 20 min at room temperature and made
permeable with 0.1% Triton X-100 in phosphate-buffered
saline. Cells were labeled with the appropriate antibod-
ies and with fluorescein and Texas red-conjugated sec-
ondary antibodies. Coverslips were mounted in Moviol
and viewed by epifluorescence on a Zeiss Axiomat pho-
tomicroscope or a laser confocal microscope (LCM
Zeiss 310) with a 633 planar objective. Cryosectioning
nd immunogold analysis were performed as detailed
lsewhere (Liou et al., 1996).
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